The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer
Luxi Yin(Apple (Israel)), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingjing Li(Peking University), Qi Xu(China Jiliang University), Qing Wei(Chinese Academy of Sciences)
Cited by 4
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
|JAMA|2023|384
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
|Cancer Immunology Research|2017|363